Tofranil and pyrexia Patient Reports February 12, 2012

Tofranil Side Effects Report #5058236-5
Tofranil side effect was reported by a Consumer or non-health professional from JAPAN on July 05, 2006. Female patient, 50 years of age, was diagnosed with major depression and was treated with Tofranil. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, muscle rigidity, neuroleptic malignant syndrome, pyrexia. Tofranil dosage: 150 MG/D. During the same period patient was treated with RISPERIDONE, OLANZAPINE, CHLORPROMAZINE, SULPIRIDE, AMOXAPINE, PAROXETINE, FLUVOXAMINE MALEATE. Patient was hospitalized. Patient recovered.

Tofranil Side Effects Report #5060651-0
Tofranil side effect was reported by a Consumer or non-health professional from JAPAN on July 05, 2006. Female patient, 50 years of age, was diagnosed with major depression and was treated with Tofranil. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, muscle rigidity, neuroleptic malignant syndrome, pyrexia. Tofranil dosage: 150 MG/D. During the same period patient was treated with RISPERIDONE, OLANZAPINE, CHLORPROMAZINE, SULPIRIDE, AMOXAPINE, PAROXETINE, FLUVOXAMINE MALEATE. Patient was hospitalized. Patient recovered.

Tofranil Side Effects Report #5396218-4
Tofranil side effect was reported by a Physician from JAPAN on July 18, 2007. Female patient, 48 years of age, was diagnosed with irritable bowel syndrome  and was treated with Tofranil. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, liver disorder, pyrexia. Tofranil dosage: unknown. During the same period patient was treated with POLYCARBOPHIL CALCIUM, THIATON, LANSOPRAZOLE. Patient was hospitalized. Patient recovered.

Tofranil Side Effects Report #4718447-2
Tofranil side effect was reported by a Physician from JAPAN on July 08, 2005. Male patient, 56 years of age, was diagnosed with depressed mood and was treated with Tofranil. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, depressed level of consciousness, muscular weakness, neuroleptic malignant syndrome, pyrexia. Tofranil dosage: unknown. Patient was hospitalized. Patient recovered.


Tofranil Side Effects Report #5230375-5
Tofranil side effect was reported by a Consumer or non-health professional from BRAZIL on Jan 26, 2007. Male patient, 13 years of age, weighting 136.7 lb, was diagnosed with convulsion and was treated with Tofranil. After drug was administered, patient experienced the following side effects: hallucination, insomnia, pyrexia. Tofranil dosage: 10 MG, QD. Patient recovered.

Tofranil Side Effects Report #5073415-9
Tofranil side effect was reported by a Physician from JAPAN on July 26, 2006. Male patient, 79 years of age, was diagnosed with benign prostatic hyperplasia and was treated with Tofranil. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, liver disorder, pyrexia. Tofranil dosage: unknown. During the same period patient was treated with HARNAL. Patient was hospitalized. Patient recovered.

Tofranil Side Effects Report #5093078-6
Tofranil side effect was reported by a Physician from JAPAN on July 26, 2006. Male patient, 79 years of age, weighting 147.7 lb, was diagnosed with benign prostatic hyperplasia and was treated with Tofranil. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, gamma-glutamyltransferase increased, liver disorder, pyrexia. Tofranil dosage: 10 MG/D. During the same period patient was treated with HARNAL. Patient was hospitalized. Patient recovered.

Tofranil Side Effects Report #5103717-9
Tofranil side effect was reported by a Physician from JAPAN on July 26, 2006. Male patient, 79 years of age, weighting 147.7 lb, was diagnosed with benign prostatic hyperplasia and was treated with Tofranil. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, gamma-glutamyltransferase increased, liver disorder, pyrexia. Tofranil dosage: 10 MG/D. During the same period patient was treated with HARNAL. Patient was hospitalized. Patient recovered.